Dr. Suzanne LeBlang, Chief Medical Officer at the Focused Ultrasound Foundation and also a Radiologist at UNIVERSITY MRI in Boca Raton, Florida joins eHealth Radio and the Female Health & Health News Channels. Suzanne is here to talk about Fibroids Awareness Week, and what women should know about new advances in treatment for this condition.
Listen to interview with host Eric Michaels and guest Dr. Suzanne LeBlang discuss the following:
Can you explain to our aud...
Dr. Suzanne LeBlang, Chief Medical Officer at the Focused Ultrasound Foundation and also a Radiologist at UNIVERSITY MRI in Boca Raton, Florida joins eHealth Radio and the Female Health & Health News Channels. Suzanne is here to talk about Fibroids Awareness Week, and what women should know about new advances in treatment for this condition.
Listen to interview with host Eric Michaels and guest Dr. Suzanne LeBlang discuss the following:
- Can you explain to our audience: what are uterine fibroids?
- How common are fibroids, and what are the symptoms?
- How do fibroids affect a woman’s fertility?
- What are the most common treatments for fibroids, and what are the pros/cons of each?
- Are there any new, less-invasive treatments that help women preserve their fertility options?
Suzanne LeBlang, MD, is a neuroradiologist and an early adopter of MR-guided focused ultrasound (MRgFUS) who has used the technology to treat patients for more than 10 years. She is based in Boca Raton, Florida and is affiliated with multiple hospitals in the area, including JFK Medical Center and West Boca Medical Center. She received her medical degree from University of Miami Miller School of Medicine and has been in practice for more than 20 years. Dr. LeBlang is one of 85 doctors at JFK Medical Center and one of 26 at West Boca Medical Center who specialize in Radiology.
As the Chief Medical Officer at the Focused Ultrasound Foundation, Dr. LeBlang organizes working groups to devise clinical protocols, serve as a liaison to the clinical research community, and present information on MRgFUS at medical conferences.
Dr. LeBlang’s research, “Leiomyoma Shrinkage After MR-Guided Focused Ultrasound Treatment: Report of 80 Patients,” published in Radiology in 2010, was one of the first papers to document that a more extensive nonperfused volume after an MRgFUS treatment resulted in greater fibroid shrinkage. She has also participated in several worldwide focused ultrasound clinical trials for fibroids and a clinical trial for patients with painful bone metastases.
Dr. LeBlang serves on the faculty at the University of Miami Medical School where she is the Radiology Clinical Coordinator for the 3rd year M.D./M.P.H. students, and she teaches at the Florida Atlantic University Schmidt College of Medicine. She has been visiting faculty at several institutions including Harvard University and Ohio State University.
Website: www.fibroideducation.com
Social Media Links:
Twitter: @FibroidEdCenter
Facebook: https://www.facebook.com/FibroidEducationCenter
View more
